Skip to main navigation
  • Media
  • Contact
  • Login
Guardant Health
  • Our Company
    • Mission
    • Leadership
  • Clinical Studies
    • ECLIPSE
  • Solutions
    • Treatment Selection
    • Recurrence Detection
    • Early Detection
  • International
  • Investors
    • Press Releases
    • Events
    • Corporate Governance
      • Leadership
      • Board of Directors
      • Committee Composition
      • Governance Documents
    • SEC Filings
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • FAQs
    • Email Alerts
    • Investor Contact
  • Careers
    • Join our Mission
    • Making Their Mark
    • Our Values
    • Benefits
    • Jobs
  • Menu

Investors

  • Press Releases
  • Events
  • Corporate Governance
    • Leadership
    • Board of Directors
    • Committee Composition
    • Governance Documents
  • SEC Filings
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • FAQs
  • Email Alerts
  • Investor Contact

Event Details

Guardant Health at the UBS Genomics 2.0 Summit

08-07-2019

Supporting Materials

UBS Genomics 2.0 Summit Investor Presentation 3.5 MB
  • Print Page
  • Email Page
  • Email Alerts
  • RSS Feeds

Our Company

Mission

Leadership

International

Solutions

Treatment Selection

Recurrence Detection

Early Detection

Careers

Join our Mission

Making Their Mark

Our Values

Benefits

Jobs

Investors

Press Releases

Events

Corporate Governance

SEC Filings

Stock Information

FAQs

Email Alerts

Investor Contact

Guardant Health, Inc.

505 Penobscot Dr.
Redwood City, CA 94063

Telephone: 855.698.8887
Fax: 888.974.4258

Contact us:
clientservices@guardanthealth.com

Media inquiries:
press@guardanthealth.com

© 2020 Guardant Health, Inc ALL RIGHTS RESERVED
CLIA # 05D2070300 | CAP Accredited # 8765297